Stock listing

Transmedics Group, Inc.

Selected listing: 8T8 · MUN · EUR · DE

Transmedics Group, Inc. (Munich:8T8), Health Technology. Latest release Sep 10, 2026: TransMedics Appoints Fernando Araujo as Chief Financial Officer…

8T8:MUNEURDEUpdated October 2, 2026

Ticker: Munich:8T8
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Munich
Currency: EUR

About Transmedics Group, Inc.

The company focuses on innovative solutions in the field of organ transplantation. Transmedics aims to improve patient outcomes through its advanced technologies and services.

Latest news from Transmedics Group, Inc.

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

September 10, 2026

TransMedics Reports Second Quarter 2026 Financial Results

August 4, 2026

TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

July 28, 2026

TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH

July 6, 2026

All Transmedics Group, Inc. news →

Events

Replays

TransMedics Group, Inc. (TMDX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
TransMedics Group, Inc. (TMDX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 04:30 PM ET
Watch

Research Transmedics Group, Inc.

Transmedics Group, Inc. company profile

View the public company page for Transmedics Group, Inc. on 6ix.

Transmedics Group, Inc. news

Read company news and market updates connected to Transmedics Group, Inc..

Transmedics Group, Inc. investor events

Find investor webinars, events, and replay context for Transmedics Group, Inc..